Speaking Faculty to Date:
John Crison, Ph.D, Medivas
Uday Kompella, Associate Professor of Pharmaceutics & Ophthalmology, University of Nebraska Medical Center
Ashim Mitra, Ph.D Missouri Curators’ Professor and Chairman of Pharmaceutical Sciences Vice- Provost for Interdisciplinary Research, University of Missouri
Dr. Bozena Michniak, New Jersey Center for Biomaterials and Rutgers University
Richard Mc.Gregor, Director, Business Development, Linguagen
Vishal Gupta, Ph.D., Director, Tyco Healthcare
Paul Jenkins, VP Commercial, Phoqus Pharmaceuticals
Steven J. Shire, Ph.D., Staff Scientist and Group Leader, Pharmaceutical Research and Development Dept., Genentech, Inc.
David Urquhart, Ph.D., The Medical House
Edward T. Maggio, Ph.D, President and CEO, Aegis Therapeutics, LLC
Marc Giroux, CEO, Kurve Technology, Inc
Ola Nerbrink, Principal Scientist, Device Chemistry & Biology, Novo Nordisk
Raj Bawa, Ph.D, President, Bawa Biotechnology Consulting, LLC; Advisor, Office of Technology Commercialization, Rensselaer Polytechnic Institute
Martin Woodle, Ph.D, CST, Intradigm Corp
Omid C. Farokhzad, M.D.,Assistant Professor of Anesthesia, Harvard Medical School Laboratory of Nanomedicine and Biomaterials, Dept of Anesthesology, Perioperative and Pain Medicine, Brigham and Women's Hospital
Phyllis Gardner, MD, Associate Professor, Department of Medicine, Stanford University School of Medicine
Aleksandr Noy, UC Davis/Livermore Labs
Todd Sulchek, Ph.D UC Davis/Livermore Labs
Deni Zodda, PhD, V-P, Discovery Laboratories, Inc
Tamara C. Baynham, Ph.D, Senior Research Scientist, Guidant Corporation
Sonya Summerour-Clemmons, PhD, MBA, Director of Business Development, Medivas
Jon Meyer, MSc, MBA, Associate Director, Life Sciences, Navigant Consulting, Inc.
|
DRUG DELIVERY 2006
Where Science and Business Meet
May 17th - 19th, 2006
Hilton San Diego/Del Mar, San Diego, CA
Download Conference Brochure
Request Information on Sponsorship Opportunities
Request Information on Exhibitor Opportunities
Drug Delivery 2006 is designed to bring together expert speakers from the Drug Delivery,
Pharmaceutical, Biotechnology, Device and Venture Capital fields. It offers six distinct
scientific tracks covering the latest discoveries and trends in nanotechnology,
transdermal, ophthalmic, oral, injectables and nasal/pulmonary delivery, while the business
and science track provides practical, actionable information about the latest issues
relevant to the entire drug delivery community including scientific sessions that cross
over between the specialties.
At this conference, discover:
- The latest advances in drug delivery in the following fields:
- nanotechnology
- transdermal
- ophthalmic
- oral
- injectables
- nasal/pulmonary
- The challenges and opportunities facing the drug delivery community as a whole
- The most promising novel delivery systems for macromolecules, proteins, peptides and nanoparticles
- Why particle engineering and biomaterials are key to the advancement of drug delivery
- What drug delivery systems are currently in development
- The latest Industry partnering trends
- How to transition from a drug delivery company to a pharmaceutical company
- How to attract venture capital
...and more!
Attend one of the Pre-Conference Workshops:
Workshop A: Dealmaking and the Drug Delivery Company: From Valuation to Negotiation
Workshop B: Moving Products into New Drug Delivery Systems
|
To receive a registration reminder please click here.
|
